Clinical Trial Update: A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy. [NA]

View source ↗

Summary

This is a completed feasibility trial evaluating CLS PD, a peritoneal dialysis system that continuously regenerates intraperitoneal fluid to remove toxins and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Triomed AB | Conditions: Peritoneal Dialysis | NA | Status: COMPLETED